Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

Go back to Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
(NASDAQ: COCH) Delayed: 0.65 +0.02 (3.17%)
Previous Close $0.63    52 Week High $ 
Open $0.64    52 Week Low $ 
Day High $0.68    P/E N/A 
Day Low $0.63    EPS $ 
Volume 72,214